- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06358729
Pre-Pregnancy Weight Loss and Baby Behavior Study
April 28, 2026 updated by: Amanda Kinney Crandall, University of Michigan
The Impact of Pre-Pregnancy Weight Loss on Infant Sucking Behavior in Response to a Challenging Nipple
This study will help researchers learn more about how babies respond to bottle nipples with larger or smaller holes.
Researchers guess that infants of mothers with obesity who did not lose weight prior to pregnancy will have the greatest Suck Effect on the challenging compared with the typical nipple.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The researchers will recruit babies from the original cohort in the PLAN study (NCT03244722), regardless of which arms they participated in.
However, the researchers will test the study arms from the original PLAN study for effects on the study's dependent variables.
Their between-subjects arms included Pre-pregnancy obesity with intensive weight loss intervention, pre-pregnancy obesity with standard of care intervention, and pre-pregnancy healthy weight with no intervention.
So, although the researchers are not assigning babies to any arms, their original assignment will still be assessed the study analysis.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- The University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
To be eligible to participate in this study...
Mother
-Current or previous participation in the PLAN study resulting in a live birth.
Child
- Mother participated in PLAN study during child's gestation
- Infant birth weight (From PLAN study records) appropriate (≥ 3rd percentile and ≤ 97th percentile) for gestational age and sex based on US Natality Data set (Oken et al, BMC Pediatrics 2003).
- Infant is 3.0 to 6.0 months old at Consent.
- Biological mother is legal guardian by maternal report.
- Biological mother is full time custodial guardian by maternal report (versus sharing custody such that infant does not live with her full time).
- Infant typically consumes at least 2 ounces in one feeding from an artificial nipple and bottle at least once per week by maternal report.
- Stated willingness by mother to comply with all study procedures and availability for the duration of the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nipple order 1
First the typical nipple and then challenging nipple
|
Infants are fed their typical milk/formula by their caregiver when hungry, one feeding with their typical nipple.
Infants are fed with a smaller sized nipple (i.e. with a smaller aperture, slowing the rate of milk delivery).
|
|
Experimental: Nipple order 2
First the challenging nipple and then the typical nipple
|
Infants are fed their typical milk/formula by their caregiver when hungry, one feeding with their typical nipple.
Infants are fed with a smaller sized nipple (i.e. with a smaller aperture, slowing the rate of milk delivery).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suck effect
Time Frame: Up to 6 weeks
|
Sucking will be measured with the NFANT® Feeding Solution
|
Up to 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sucking pressure
Time Frame: Up to 6 weeks
|
Sucking will be measured with the NFANT® Feeding Solution
|
Up to 6 weeks
|
|
Sucking frequency
Time Frame: Up to 6 weeks
|
Sucking will be measured with the NFANT® Feeding Solution
|
Up to 6 weeks
|
|
Milk/Formula intake
Time Frame: Up to 6 weeks
|
Up to 6 weeks
|
|
|
Milk/Formula consumption rate
Time Frame: Up to 6 weeks
|
Up to 6 weeks
|
|
|
Number of Feedings Over 24 Hours
Time Frame: Up to 6 weeks
|
Up to 6 weeks
|
|
|
Total Hours of Sleep per 24 Hours within 24 hours of intervention
Time Frame: Up to 6 weeks
|
Up to 6 weeks
|
|
|
Total Night Wake-ups within 24 hours of intervention
Time Frame: Up to 6 weeks
|
Up to 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julie Lumeng, MD, University of Michigan
- Principal Investigator: Amanda Crandall, PhD, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 13, 2025
Primary Completion (Actual)
July 10, 2025
Study Completion (Actual)
July 22, 2025
Study Registration Dates
First Submitted
April 5, 2024
First Submitted That Met QC Criteria
April 5, 2024
First Posted (Actual)
April 11, 2024
Study Record Updates
Last Update Posted (Actual)
May 5, 2026
Last Update Submitted That Met QC Criteria
April 28, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00239775
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The researchers may consider sharing data but hesitate due to difficulties de-identifying data of small samples.
Please contact the study team if you have questions.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
The University of Texas Health Science Center at...The University of Texas at San AntonioCompleted
-
Gynuity Health ProjectsCuidado Integral de la Mujer, Gineclinic, S.C.; Servicios de Salud Medieg,...Not yet recruitingPregnancy Related | Pregnancy Early
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Université Catholique de LouvainRecruiting
-
Oregon Health and Science UniversityRecruitingPregnancy RelatedUnited States
-
Biorithm Pte LtdRecruiting
Clinical Trials on Typical Nipple
-
Changhua Christian HospitalMinistry of Science and Technology, Taiwan; Intuitive SurgicalRecruiting
-
The University of Hong KongNew Life Psychiatric Rehabilitation AssociationNot yet recruitingMental WellbeingHong Kong
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingBreast Cancer | Invasive Breast Carcinoma | Ductal Carcinoma In Situ, DCISChina
-
Severance HospitalSamsung Medical Center; Asan Medical Center; Kyungpook National University Chilgok...Active, not recruitingBreast Neoplasms | Benign Breast Disease | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene Mutation | Germline Mutation AbnormalityKorea, Republic of
-
Yonsei UniversityRecruitingBreast Cancer Classified as TNM Stage 0-IIIaSouth Korea
-
Hadassah Medical OrganizationUnknown
-
Changhua Christian HospitalMinistry of Science and Technology, Taiwan; Intuitive SurgicalUnknownBreast Cancer FemaleTaiwan, Korea, Republic of, Italy
-
Severance HospitalSamsung Medical Center; Changhua Christian Hospital; European Institute of OncologyCompletedRecurrence | Postoperative Complications | Breast Cancer | Breast Neoplasms | Surgery | Surgery--Complications | BRCA1 Mutation | BRCA2 MutationKorea, Republic of
-
Hillel Yaffe Medical CenterUnknownPremature Rupture of Fetal MembranesIsrael
-
Wake Forest University Health SciencesCompletedBreast Cancer | Breast Reconstruction | CosmesisUnited States